Lung Cancer: Late-Breaking Abstracts: Lung Cancer Mechanisms |

Antisense Long Noncoding RNA LOC285194 is Downregulated in NSCLC and Associated With Poor Prognosis FREE TO VIEW

Xiaoshun Shi, MD; Yaoqi Chen, MD; Jingyi Chen, MS; Fenglan Feng, MS; Jin Li, PhD; Jianxing He, MD
Author and Funding Information

Copyright 2016, American College of Chest Physicians. All Rights Reserved.

Chest. 2016;149(4_S):A256. doi:10.1016/j.chest.2016.02.268
Text Size: A A A
Published online

SESSION TITLE: Late-Breaking Abstracts: Lung Cancer Mechanisms

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Sunday, April 17, 2016 at 08:30 AM - 09:30 AM

PURPOSE: Long non-coding RNAs (lncRNAs) have emerged recently as major players in tumor biology and may be used for cancer diagnosis, prognosis, and potential therapeutic targets. Although down-regulation of lncRNA LOC285194 in several cancer types has been claimed, its role in lung cancer remains unknown. The aim of our study is to investigate the expression and clinical significance of lncRNA LOC285194 in non small cell lung cancer.

METHODS: The expression of lncRNA LOC285194 was detected by quantitative real-time PCR (qRT-PCR) in 66 pairs of tumor tissues and adjacent non-tumor tissues of lung cancer patients. Then, we analyzed the lncRNA LOC285194 expression levels against clinicopathological features and survival status in lung cancer. The proliferation, apoptosis, invasion and migration ability of A549 and H1299 cells with LOC285194 force expression were examined. NSCLC cells transfected with pCDNA-LOC285194 were injection into nude mice to investigate the effect of LOC285194 on tumorigenesis in vivo.

RESULTS: We found that lncRNA LOC285194 expression was down-regulated in tumor tissues compared with adjacent non-tumor tissues which was associated with tumor size. Kaplan-Meier analysis showed that patients with low lncRNA LOC285194 expression had a poor overall survival than those with high lncRNA LOC285194 expression. Moreover, univariate and multivariate analyses showed that low lncRNA LOC285194 expression was an independent poor prognostic factor for lung cancer patients. Overexpression of LOC285194 inhibited NSCLC cell proliferation, invasion and migration in vitro and in vivo. The growth inhibition by LOC285194 may be partially through the interaction with p53 protein.

CONCLUSIONS: Our results provided the first evidence that lncRNA LOC285194 might be a novel prognostic tumor-suppressing indicator in lung cancer and molecular mechanisms of lncRNA LOC285194 that involved in lung cancer need to be further studied.

CLINICAL IMPLICATIONS: The study indicates that lncRNA LOC285194 is down-regulated in lung cancer tissues and might be an independent molecular biomarker for predicting the prognosis of lung cancer patients. This new findings indicated that lncRNA LOC285194 may be used as a potential target for diagnosis and gene therapy of lung cancer. However, the precise molecular mechanisms of lncRNA LOC285194 that involved in lung cancer need to be further studied.

DISCLOSURE: The following authors have nothing to disclose: Xiaoshun Shi, Yaoqi Chen, Jingyi Chen, Fenglan Feng, Jin Li, Jianxing He

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543